Quantitative prediction of oral cancer risk in patients with oral leukoplakia

Yao Liu; Yicheng Li; Yue Fu; Tong Liu; Xiaoyong Liu; Xinyan Zhang; Jie Fu; Xiaobing Guan; Tong Chen; Xiaoxin Chen; Zheng Sun

doi:10.18632/oncotarget.17550

Oncotarget

Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.

Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial, Introducing Oncotarget.

As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.

Subscribe to receive alerts once a paper has been published by Oncotarget.

Impact Journals, LLC is the publisher of Oncotarget: www.impactjournals.com.

Impact Journals is a member of the Wellcome Trust List of Compliant Publishers.

Impact Journals is a member of the Society for Scholarly Publishing.

On December 23, 2022, Oncotarget server experienced a DDoS attack. As a result, Oncotarget site was inaccessible for a few hours. Oncotarget team swiftly dealt with the situation and took it under control. This malicious action will be reported to the FBI.

Research Papers:

Quantitative prediction of oral cancer risk in patients with oral leukoplakia

Yao Liu, Yicheng Li, Yue Fu, Tong Liu, Xiaoyong Liu, Xinyan Zhang, Jie Fu, Xiaobing Guan, Tong Chen, Xiaoxin Chen _ and Zheng Sun

PDF | HTML | Supplementary Files | How to cite

Oncotarget. 2017; 8:46057-46064. https://doi.org/10.18632/oncotarget.17550

Metrics: PDF 2045 views | HTML 2739 views | ?

Abstract

Yao Liu1,*, Yicheng Li2,*, Yue Fu1, Tong Liu1, Xiaoyong Liu3, Xinyan Zhang4, Jie Fu1, Xiaobing Guan1, Tong Chen5, Xiaoxin Chen2 and Zheng Sun1

1Department of Oral Medicine, Beijing Stomatological Hospital, Capital Medical University, Beijing, China

2Cancer Research Program, Julius L. Chambers Biomedical Biotechnology Research Institute, North Carolina Central University, Durham, North Carolina, USA

3Department of Pathology, Beijing Stomatological Hospital, Capital Medical University, Beijing, China

4Beijing Institute of Dental Research, School of Stomatology, Capital Medical University, Beijing, China

5Division of Medical Oncology, Department of Internal Medicine, The Ohio State University, Columbus, Ohio, USA

*These authors have contributed equally to this work

Correspondence to:

Xiaoxin Chen, email: [email protected]

Zheng Sun, email: [email protected]

Keywords: exfoliative cytology, oral cancer risk, oral leukoplakia, oral squamous cell carcinoma, quantitative prediction

Received: January 13, 2017 Accepted: February 28, 2017 Published: May 02, 2017

ABSTRACT

Exfoliative cytology has been widely used for early diagnosis of oral squamous cell carcinoma. We have developed an oral cancer risk index using DNA index value to quantitatively assess cancer risk in patients with oral leukoplakia, but with limited success. In order to improve the performance of the risk index, we collected exfoliative cytology, histopathology, and clinical follow-up data from two independent cohorts of normal, leukoplakia and cancer subjects (training set and validation set). Peaks were defined on the basis of first derivatives with positives, and modern machine learning techniques were utilized to build statistical prediction models on the reconstructed data. Random forest was found to be the best model with high sensitivity (100%) and specificity (99.2%). Using the Peaks-Random Forest model, we constructed an index (OCRI2) as a quantitative measurement of cancer risk. Among 11 leukoplakia patients with an OCRI2 over 0.5, 4 (36.4%) developed cancer during follow-up (23 ± 20 months), whereas 3 (5.3%) of 57 leukoplakia patients with an OCRI2 less than 0.5 developed cancer (32 ± 31 months). OCRI2 is better than other methods in predicting oral squamous cell carcinoma during follow-up. In conclusion, we have developed an exfoliative cytology-based method for quantitative prediction of cancer risk in patients with oral leukoplakia.

All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 17550

Publication Alerts

Research Papers:

Quantitative prediction of oral cancer risk in patients with oral leukoplakia

Abstract